Pharmacy

Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment

Monday, April 6, 2020 - 1:00am

SONGDO, South Korea, April 5, 2020 /PRNewswire/ --Samsung Biologics (207940.KS) entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders.

Key Points: 
  • SONGDO, South Korea, April 5, 2020 /PRNewswire/ --Samsung Biologics (207940.KS) entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders.
  • Under this agreement, Samsung will provide the full scope of its CDO services from cell line development, process development, cGMP clinical manufacturing to IND filing support.
  • PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease.
  • "Offering full range of services in development, manufacturing, and laboratory testing from our state-of-the-art facilities, Samsung Biologics works intimately with our clientsto reach IND and market Faster & Better," said Tae-Han Kim, CEO of Samsung Biologics.

Mako Medical Launches Programs Aimed at Helping Seniors at Risk of COVID-19

Sunday, April 5, 2020 - 10:02pm

ATLANTA, April 5, 2020 /PRNewswire/ --Mako Medical launched a new program focused on helping seniors and those at greater risk of contracting the Coronavirus.

Key Points: 
  • ATLANTA, April 5, 2020 /PRNewswire/ --Mako Medical launched a new program focused on helping seniors and those at greater risk of contracting the Coronavirus.
  • Mako Medical is partnering with medical practices to expand services to include in-home check-ups, RX delivery, and lab draws.
  • Since the elderly are most vulnerable, many have stayed home even when they need prescription refills, routine check-ups, and general medical care.
  • Mako Medical laboratories and Mako Medical is an award-winning leader in Pharmacy and Laboratory services.Mako is known for its extensive community service, hiring military veterans, and leveraging technology for its services.

ASHP Calls on Trump Administration to Give States Access to Drugs Needed to Treat Ventilated COVID-19 Patients

Friday, April 3, 2020 - 11:41pm

"Even if hospitals had all of the ventilators needed to keep patients alive, this critical shortage of medications could make it impossible to maintain COVID-19 patients on those ventilators, and therefore result in harm," said ASHP CEO Paul W. Abramowitz, Pharm.D., Sc.D.

Key Points: 
  • "Even if hospitals had all of the ventilators needed to keep patients alive, this critical shortage of medications could make it impossible to maintain COVID-19 patients on those ventilators, and therefore result in harm," said ASHP CEO Paul W. Abramowitz, Pharm.D., Sc.D.
  • Since the COVID-19 crisis began, ASHP has reached out to federal agencies and Congress to protect our critical drug supply.
  • For more than 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety.
  • For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP's website, ashp.org , or its consumer website, SafeMedication.com .

Publix Pharmacy Expands Hours

Friday, April 3, 2020 - 10:51pm

To better serve customers during the coronavirus pandemic, Publix Pharmacy is expanding hours chainwide beginning Monday, April 6.

Key Points: 
  • To better serve customers during the coronavirus pandemic, Publix Pharmacy is expanding hours chainwide beginning Monday, April 6.
  • The expanded hours are Monday through Friday, 9 a.m. 7 p.m., and normal hours on Saturday and Sunday.
  • In-store pharmacies will continue to be open on Tuesdays and Wednesdays during shopping hours for customers age 65 and over.
  • Publix, the largest employee-owned company in the U.S. with more than 200,000 associates, currently operates 1,242 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia.

Walgreens Implementing Additional Safety Measures to Protect Employees and Customers

Friday, April 3, 2020 - 9:30pm

Ensuring the health and safety of its team members, customers and communities is Walgreens top priority, now more than ever.

Key Points: 
  • Ensuring the health and safety of its team members, customers and communities is Walgreens top priority, now more than ever.
  • Additional hand sanitizer for team members, as well as customers, is also being provided.
  • Our pharmacists and team members are playing a critical role in supporting Walgreens customers and patients at an unprecedented time of need in our country, said Walgreens President, Richard Ashworth.
  • Walgreens has introduced a number of other service offerings to provide our customers greater convenience while practicing social distancing.

Mako Medical CEO Announces New Technology Targeted at Saving Independent Medical Practices Hurt by COVID-19

Friday, April 3, 2020 - 12:00pm

RALEIGH, N.C., April 3, 2020 /PRNewswire/ --Mako Medical rolls out a new technology and in-home services aimed at helping doctors and patients affected by COVID-19.

Key Points: 
  • RALEIGH, N.C., April 3, 2020 /PRNewswire/ --Mako Medical rolls out a new technology and in-home services aimed at helping doctors and patients affected by COVID-19.
  • Medical practices around the country have seen a drastic decrease in patient volume because of COVID-19.
  • With most of the country under a lockdown and with many states implementing shelter orders, medical practices across the country are scrambling to address the sharp decline in patient volume to their practices.
  • Mako Medical is an award-winning leader in pharmacy and lab services.Mako is known for its extensive community service, hiring military veterans, and leveraging technology for its services.

Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering

Friday, April 3, 2020 - 2:22am

NEW YORK and SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the pricing of its initial public offering of 9,180,000 shares of common stock at a public offering price of $18.00 per share, for total gross proceeds of approximately $165.2 million, before deducting underwriting discounts and commissions and offering expenses payable by Zentalis.

Key Points: 
  • NEW YORK and SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the pricing of its initial public offering of 9,180,000 shares of common stock at a public offering price of $18.00 per share, for total gross proceeds of approximately $165.2 million, before deducting underwriting discounts and commissions and offering expenses payable by Zentalis.
  • The offering is expected to close on April 7, 2020, subject to customary closing conditions.
  • In addition, Zentalis has granted the underwriters a 30-day option to purchase up to an additional 1,377,000 shares of its common stock at the initial public offering price less the underwriting discounts and commissions.
  • Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers.

Know Your Health Care Rights: 6 Tips for California Consumers During the COVID-19 Pandemic

Thursday, April 2, 2020 - 9:08pm

LOS ANGELES, April 2, 2020 /PRNewswire/ --Consumer Watchdog released a "Know Your Rights"tip sheettoday outlining 6things consumers should knowabouttheirhealth care cost and access rights during the COVID-19 pandemic.

Key Points: 
  • LOS ANGELES, April 2, 2020 /PRNewswire/ --Consumer Watchdog released a "Know Your Rights"tip sheettoday outlining 6things consumers should knowabouttheirhealth care cost and access rights during the COVID-19 pandemic.
  • California consumers and patients should know theirlegalrights asCOVID-19 is expected to heavily tax the resources of the health care systemand may exceed capacity insome communities,potentially resulting inlimitations on access to care,according to the non-profitand non-partisanConsumer Watchdog.
  • "We encourage California patients to wash their hands, respect social distancing rules, and know your health care rights!"
  • To ensure continued access to prescription medications while promoting social distancing during the COVID-19 pandemic, health insurersmayrelaxrefillrestrictionson "maintenance" prescriptionsfor chronic conditions.

Kirby McInerney Announces Settlement of a False Claims Act Whistleblower Suit against Compounding Pharmacy FPR Specialty Pharmacy and Its Owners  

Thursday, April 2, 2020 - 10:36pm

Kirby McInerney LLP has settled a significant False Claims Act case on behalf of a whistleblower client against a compounding pharmacy FPR Specialty Pharmacy, its owners Christopher Casey and Billy Rue, and affiliated business Mead Square Pharmacy, all from the Rochester, New York area.

Key Points: 
  • Kirby McInerney LLP has settled a significant False Claims Act case on behalf of a whistleblower client against a compounding pharmacy FPR Specialty Pharmacy, its owners Christopher Casey and Billy Rue, and affiliated business Mead Square Pharmacy, all from the Rochester, New York area.
  • First, they shipped their pain cream to states in which they did not have licenses to practice as a pharmacy.
  • When they eventually applied for pharmacy licenses, they misled the state pharmacy boards about their prior unlicensed sales and obscured Caseys prior disqualifying personal conduct.
  • On the whistleblowers behalf, Kirby McInerney filed a qui tam action in 2016 under the False Claims Act against Casey, Rue, FPR Specialty Pharmacy, and Mead Square Pharmacy.

Hosted by LabRoots, BioProcessing 2020 Returns April 8th to Highlight Innovations in Cell and Gene Therapies, Process Characterization and Biomanufacturing

Thursday, April 2, 2020 - 3:00pm

More than 11,000 scientists, researchers, engineers, technologists from industry, and academia will come together globally to focus on new solutions to maximize quality, risk management, and cost-efficiency in the biologics manufacturing process.

Key Points: 
  • More than 11,000 scientists, researchers, engineers, technologists from industry, and academia will come together globally to focus on new solutions to maximize quality, risk management, and cost-efficiency in the biologics manufacturing process.
  • This unique forum will reveal the latest advancements in cell-gene therapies and shared insights in the most effective manufacturing methods.
  • Among these highlights, Dr. Robert Kruse a resident physician at John Hopkins, will deliver a keynote address explaining new paradigms in moving toward Point-of-Care Cell Therapy Services in the hospital.
  • Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities.